Target Name: MIR6890
NCBI ID: G102465536
Other Name(s): hsa-miR-6890-3p | hsa-miR-6890-5p | MicroRNA 6890 | hsa-mir-6890 | microRNA 6890 | microRNA mir-6890

MIR6890: A Potential Drug Target for Cancer

MIR6890 (hsa-miR-6890-3p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to study.

MIR6890 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. miRNAs have been shown to have a wide range of functions, including regulating cell growth, cell cycle progression, and apoptosis.

One of the reasons why MIR6890 has gained so much attention is its unique expression pattern. MIR6890 is highly expressed in most tissues and cells, but its expression level is highly variable between different cell types and tissues. This variability makes it an ideal candidate for a drug target, as targeting a protein that is expressed in a wide range of cells could be difficult.

In addition, MIR6890 has been shown to play a role in various diseases, including cancer. Studies have shown that MIR6890 is highly expressed in many types of cancer, including breast, ovarian, and colorectal cancer. Additionally, MIR6890 has been shown to be involved in the regulation of cell cycle progression and apoptosis, which are important processes in cancer development.

Furthermore, MIR6890 has been shown to have a positive correlation with cancer outcomes. Studies have shown that higher MIR6890 expression is associated with poor prognosis in cancer patients. This suggests that targeting MIR6890 could be a promising strategy for cancer treatment.

In conclusion, MIR6890 is a promising drug target or biomarker for various diseases, including cancer. Its unique expression pattern and involvement in cell cycle progression and apoptosis make it an attractive target for researchers to study. Further studies are needed to determine the effectiveness of targeting MIR6890 as a drug or biomarker.

Protein Name: MicroRNA 6890

More Common Targets

MIR6891 | MIR6892 | MIR6893 | MIR6894 | MIR6895 | MIR7-1 | MIR7-2 | MIR7-3 | MIR7-3HG | MIR708 | MIR7106 | MIR7107 | MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG | MIR764 | MIR765 | MIR766 | MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877